331 related articles for article (PubMed ID: 33875273)
1. Emerging Roles of Coronavirus in Autoimmune Diseases.
Zhou SY; Zhang C; Shu WJ; Chong LY; He J; Xu Z; Pan HF
Arch Med Res; 2021 Oct; 52(7):665-672. PubMed ID: 33875273
[TBL] [Abstract][Full Text] [Related]
2. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
[TBL] [Abstract][Full Text] [Related]
3. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
4. De novo lupus nephritis after SARS-CoV-2 infection.
Mok CC; Chu CS; Tse SM
Lupus; 2023 Jun; 32(7):893-899. PubMed ID: 37173871
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Vahabi M; Ghazanfari T; Sepehrnia S
Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
7. The impact of the COVID-19 pandemic on SLE.
Zhao X; Wu H; Li S; Gao C; Wang J; Ge L; Song Z; Ni B; You Y
Mod Rheumatol; 2024 Feb; 34(2):247-264. PubMed ID: 36961736
[TBL] [Abstract][Full Text] [Related]
8. NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic.
Knopf J; Sjöwall J; Frodlund M; Hinkula J; Herrmann M; Sjöwall C
Cells; 2022 Aug; 11(17):. PubMed ID: 36078028
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and autoimmune diseases.
Liu Y; Sawalha AH; Lu Q
Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
[TBL] [Abstract][Full Text] [Related]
10. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and SLE: Infection and autoimmunity at its best.
Mahroum N; Elsalti A; Ozkan MF; Shoenfeld Y
Lupus; 2023 Dec; 32(14):1591-1597. PubMed ID: 37927085
[TBL] [Abstract][Full Text] [Related]
12. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review.
Gracia-Ramos AE; Saavedra-Salinas MÁ
Rheumatol Int; 2021 Apr; 41(4):799-809. PubMed ID: 33543338
[TBL] [Abstract][Full Text] [Related]
13. The potential of CD38 protein as a target for autoimmune diseases.
Ye X; Zhao Y; Ma W; Ares I; Martínez M; Lopez-Torres B; Martínez-Larrañaga MR; Wang X; Anadón A; Martínez MA
Autoimmun Rev; 2023 Apr; 22(4):103289. PubMed ID: 36750136
[TBL] [Abstract][Full Text] [Related]
14. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin in autoimmune disorders: current knowledge and future perspective.
Xu C; Wu Y; Liu N
Inflammopharmacology; 2022 Apr; 30(2):385-396. PubMed ID: 35235108
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 infection: a possible induction factor for development of autoimmune diseases?
Saeedi N; Gohari NSF; Ghalibaf AAM; Dehghan A; Owlia MB
Immunol Res; 2023 Aug; 71(4):547-553. PubMed ID: 37316687
[TBL] [Abstract][Full Text] [Related]
18. New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
[TBL] [Abstract][Full Text] [Related]
19. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.
Gracia-Ramos AE; Martin-Nares E; Hernández-Molina G
Cells; 2021 Dec; 10(12):. PubMed ID: 34944099
[TBL] [Abstract][Full Text] [Related]
20. Dermatomyositis during COVID-19 Pandemic (A Case Series): Is there a Cause Effect Relationship?
Gokhale Y; Patankar A; Holla U; Shilke M; Kalekar L; Karnik ND; Bidichandani K; Baveja S; Joshi A
J Assoc Physicians India; 2020 Nov; 68(11):20-24. PubMed ID: 33187031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
